NCT06722690

Brief Summary

The goal of this clinical trial is to learn if the eTSF intervention is feasible among Latinx young adults with alcohol use disorder. The main questions it aims to answer are:

  • Is eTSF feasible?
  • Is eTSF effective in reducing alcohol use and increasing 12-step engagement compared to the control condition? The control condition will receive educational materials on drinking problems and a list of local/online AA meetings Participants will
  • Be randomly assigned to either the eTSF condition or the control condition.
  • Fill out the baseline online survey.
  • Go through the eTSF app/control materials.
  • And at 3 months post-baseline, fill out the follow-up online survey.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
25mo left

Started Jan 2027

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 9, 2024

Completed
2.1 years until next milestone

Study Start

First participant enrolled

January 1, 2027

Expected
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2029

Last Updated

December 9, 2024

Status Verified

December 1, 2024

Enrollment Period

1.9 years

First QC Date

November 26, 2024

Last Update Submit

December 4, 2024

Conditions

Outcome Measures

Primary Outcomes (9)

  • Recruitment feasibility

    Recruitment feasibility will be measured by the number of participants screened and enrolled each month.

    Every 4 weeks up to 2 years

  • Randomization feasibility

    Randomization feasibility will be measured by the number of baseline demographic variables with statistically significant group differences.

    From recruitment to baseline assessment up to two years

  • Retention/attrition feasibility

    Retention/attrition feasibility will be measured by retention rates in each condition.

    From recruitment to the end of the trial at three months.

  • Adherence feasibility

    Adherence feasibility will be measured by the percentage of eTSF app components used by the eTSF condition participants.

    From recruitment to the end of the trial at three months.

  • Assessment feasibility

    Assessment feasibility will be measured by the proportion of missing data in each assessment.

    From recruitment to the end of the trial at three months.

  • Intervention credibility

    Intervention credibility will be measured using a single-item question: "On a scale from 1 to 5, where 1 indicates 'not at all' and 5 indicates 'very much,' to what extent do you believe this treatment will be beneficial for you?" Only eTSF condition participants will receive this measure.

    From baseline to the end of treatment at three months.

  • Intervention satisfaction

    Intervention satisfaction will be measured using the mHealth Satisfaction Questionnaire, which has a total score range from 14 to 42. Higher total scores indicate greater user satisfaction with the mHealth app.

    From baseline to the end of treatment at three months.

  • Intervention acceptability

    Acceptability will be measured using the Abbreviated Acceptability Rating Profile, which scores range from 8 to 48. Higher scores indicate greater acceptability of the intervention.

    From baseline to the end of treatment at three months.

  • Intervention engagement

    Intervention engagement will be automatically recorded by the app during the study period and be measured in terms of app opening frequency, time spent on the app per use session (i.e., the time between opening and closing the app), most frequently used intervention component, time spent per intervention component, the completion rate of each selected component, reports of technical problems.

    From baseline to the end of treatment at three months.

Secondary Outcomes (2)

  • Alcohol use

    From baseline to the end of treatment at three months.

  • 12-Step fellowship engagement

    From baseline to the end of treatment at three months.

Other Outcomes (3)

  • Drinking consequences

    From baseline to the end of treatment at three months.

  • Drug use

    From baseline to the end of treatment at three months.

  • Psychological distress

    From baseline to the end of treatment at three months.

Study Arms (2)

eTSF

EXPERIMENTAL

This arm will receive the eTSF intervention. eTSF is a smartphone app intervention featuring culturally relevant content aimed at supporting Latinx young adults with alcohol use disorder in participating in 12-step groups.

Behavioral: eTSF

Educational control

ACTIVE COMPARATOR

This arm will receive educational materials on drinking problems and a list of local/online AA meetings

Behavioral: Educational materials

Interventions

eTSFBEHAVIORAL

eTSF is a smartphone app intervention featuring culturally relevant content aimed at supporting Latinx young adults with alcohol use disorder in participating in 12-step groups.

eTSF

Educational materials on drinking problems and a list of local/online AA meetings.

Educational control

Eligibility Criteria

Age18 Years - 29 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • YAs age 18-29
  • Identify as Latinx
  • Meet the Diagnostic \& Statistical Manual of Mental Disorders 5th edition (DSM-5) diagnostic criteria for alcohol use disorder
  • Are at least minimally motivated to change their drinking (i.e., scoring ≥3 on the University of Rhode Island Change Assessment Scale's contemplation, action, or maintenance subscales and ≤3 on the precontemplation subscale)
  • Be able to provide at least one contact person to assist in tracking them for follow-up assessment

You may not qualify if:

  • Attending any 12-step program (≥2 meetings in the past month)
  • Experiencing psychotic symptoms or cognitive impairment
  • In alcohol or drug treatment programs
  • Taking addiction treatment medications
  • Experiencing, expecting to experience, or had a history of severe/complicated withdrawal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Alcoholism

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 26, 2024

First Posted

December 9, 2024

Study Start (Estimated)

January 1, 2027

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

February 1, 2029

Last Updated

December 9, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

The IPD will be shared on the NIAAA Data Archive.